Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kowey

Showing results (361-370 of 451) with videos related to

Pageof 46
Sort By:
Journal of the American College of Cardiology|December 17, 2016
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II RegistryBenjamin A Steinberg, Peter Shrader, Laine Thomas, et al.
Journal of the American College of Cardiology|February 7, 2006
Predictors of adverse outcome among patients with hypertension and coronary artery diseaseCarl J Pepine, Peter R Kowey, Stuart Kupfer, et al.
Journal of the American College of Cardiology|September 9, 2017
Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF RegistryJustin B Echouffo-Tcheugui, Peter Shrader, Laine Thomas, et al.
American Heart Journal|May 22, 2012
Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapyCees B De Vos, Günter Breithardt, A John Camm, et al.
Journal of the American Heart Association|September 16, 2015
Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF)Benjamin A Steinberg, Sunghee Kim, Laine Thomas, et al.
Circulation|October 19, 2016
Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product LabelingSean D Pokorney, Peter Shrader, Laine Thomas, et al.
Circulation|April 1, 2014
Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryBenjamin A Steinberg, Sunghee Kim, Laine Thomas, et al.
JACC. Clinical Electrophysiology|May 17, 2018
Rhythm Control Versus Rate Control and Clinical Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF RegistryAmit Noheria, Peter Shrader, Jonathan P Piccini, et al.
American Heart Journal|June 20, 2017
Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)Benjamin A Steinberg, Peter Shrader, Laine Thomas, et al.
American Heart Journal|June 12, 2020
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)Larry R Jackson, Sunghee Kim, Rosalia Blanco, et al.
Pageof 46

Showing results (361-370 of 451) with videos related to

Sort By:
Pageof 46
Journal of the American College of Cardiology|December 17, 2016
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II RegistryBenjamin A Steinberg, Peter Shrader, Laine Thomas, et al.
Journal of the American College of Cardiology|February 7, 2006
Predictors of adverse outcome among patients with hypertension and coronary artery diseaseCarl J Pepine, Peter R Kowey, Stuart Kupfer, et al.
Journal of the American College of Cardiology|September 9, 2017
Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF RegistryJustin B Echouffo-Tcheugui, Peter Shrader, Laine Thomas, et al.
American Heart Journal|May 22, 2012
Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapyCees B De Vos, Günter Breithardt, A John Camm, et al.
Journal of the American Heart Association|September 16, 2015
Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF)Benjamin A Steinberg, Sunghee Kim, Laine Thomas, et al.
Circulation|October 19, 2016
Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product LabelingSean D Pokorney, Peter Shrader, Laine Thomas, et al.
Circulation|April 1, 2014
Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryBenjamin A Steinberg, Sunghee Kim, Laine Thomas, et al.
JACC. Clinical Electrophysiology|May 17, 2018
Rhythm Control Versus Rate Control and Clinical Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF RegistryAmit Noheria, Peter Shrader, Jonathan P Piccini, et al.
American Heart Journal|June 20, 2017
Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)Benjamin A Steinberg, Peter Shrader, Laine Thomas, et al.
American Heart Journal|June 12, 2020
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)Larry R Jackson, Sunghee Kim, Rosalia Blanco, et al.
Pageof 46